The former Chicago Bulls star, who hasn't lived there for years, has now officially sold the estate, giving it a new owner ...

Orman's message is clear: buying gifts with credit cards, especially when you're already in debt, is a form of self-sabotage.

Michael Saylor‘s MicroStrategy Inc. (NASDAQ:MSTR) fell in the last five sessions amid heightened volatility due to concerns over hurdles in its S&P 500 inclusion and falling Bitcoin (CRYPTO: BTC) ...

Biopharma stocks gained 9.6% in 2024, trailing the S&P 500’s 28.5% rise. Eli Lilly projects double-digit revenue growth ...

NVO, VRTX, XPO, SMCI, NU, ARM, MU, PAYC, CTAS, WBD, MNDY. Blame fiscal spending package, Fed rate hike, weak earnings.

"I want you to invest for me like a 60-year-old. I don't want you to invest like I'm young, because I want to live off this ...

At 79, Dan Weiss has found an unconventional way to stay active, earn a solid income and connect with people – assembling ...

On the other hand, the average 401 (k) grows at a steady rate of about 5-8% annually, which is solid but nowhere near the ...

*Terms and conditions apply. Visit Nada's website for more details. From high fashion to high-rises – developers have ...

Elon Musk wasn't always the polarizing figure we see today in climate discussions. Once celebrated as a green-tech pioneer, Musk was vocal about the urgent need to combat climate change. In 2006, he ...

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

In addition to the latest deal coverage, we include a snippet from our exclusive chat with Tony Roma's CEO Mina Haque.